Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Circulating Tumour DNA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01218152
What this trial is testing

Microarray CGH Analysis of Circulating Tumoral Plasma DNA in NF1 Patients With MPNSTs

Who this might be right for
Neurofibromatosis Type 1
KU Leuven 20
Not applicableStudy completedNCT02875652
What this trial is testing

Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU)

Who this might be right for
Choroidal Melanoma
Institut Curie 800
Testing effectiveness (Phase 2)Looking for participantsNCT06977074
What this trial is testing

PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Sun Yat-sen University 83
Not applicableLooking for participantsNCT04824950
What this trial is testing

Circulating Tumor DNA in Primary Mediastinal Large B-cell Lymphoma (PMBL)

Who this might be right for
Primary Mediastinal Large B-cell Lymphoma
Centre Henri Becquerel 87
Not applicableLooking for participantsNCT05965024
What this trial is testing

Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 377
Not applicableNot Yet RecruitingNCT07673211
What this trial is testing

Circulating cfDNA and HPV as Prognostic Biomarkers for First-Line Recurrent Metastatic Cervical Cancer

Who this might be right for
Cervical CancerRecurrent Cervical CancerMetastatic Cervical Cancer
Zhejiang Cancer Hospital 60
Not applicableUnknownNCT03677414
What this trial is testing

Analysis of Androgene Receptors Axis and DNA Damage Repair Genes in Patients With Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Medical University of Graz 59
Not applicableStudy completedNCT04241367
What this trial is testing

Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy

Who this might be right for
Pancreas Adenocarcinoma
National Cancer Center, Korea 420
Not applicableUnknownNCT04971421
What this trial is testing

Liquid Biopsies for Improving the Pre-operative Diagnosis of Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
The Netherlands Cancer Institute 450
Not applicableUnknownNCT05224596
What this trial is testing

AssesSment of Early-deteCtion basEd oN liquiD Biopsy in GASTRIC Cancer, ASCEND-Gastric

Who this might be right for
Cancer
Shanghai Zhongshan Hospital 498
Testing effectiveness (Phase 2)Active Not RecruitingNCT07422805
What this trial is testing

Circulating Tumor DNA in Melanoma Patients

Who this might be right for
MelanomaSkin Cancer
Institute of Oncology Ljubljana 176
Not applicableLooking for participantsNCT04417803
What this trial is testing

Interest of Individual Biomarkers From the Identification of Tumor Genotype by High-throughput Molecular Techniques

Who this might be right for
Lymphomas
Centre Hospitalier Universitaire Dijon 1,200
Testing effectiveness (Phase 2)Looking for participantsNCT06070012
What this trial is testing

Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma
Diwakar Davar 44
Not applicableLooking for participantsNCT07142226
What this trial is testing

Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC

Who this might be right for
Biliary Tract Cancer
CHA University 200
Not applicableStudy completedNCT03737591
What this trial is testing

The Implication of Plasma ctDNA Methylation Haplotypes in Detecting Colorectal Cancer and Adenomas

Who this might be right for
Colorectal CancerAdenoma
Fudan University 1,138
Not applicableLooking for participantsNCT05788744
What this trial is testing

Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Cancer
Copenhagen University Hospital at Herlev 1,000
Not applicableStudy completedNCT05255133
What this trial is testing

Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment

Who this might be right for
Neuroendocrine Tumors
Universiteit Antwerpen 22
Large-scale testing (Phase 3)Not Yet RecruitingNCT06446557
What this trial is testing

De-scalation or swItch of Treatment According to Circulating tuMOr DNA Variation After 2 Cycles of Doublet Chemotherapy Plus Targeted Agent in Metastatic Unresectable Colorectal Cancer

Who this might be right for
Metastatic Colon Cancer
University Hospital, Rouen 408
Not applicableUnknownNCT03839706
What this trial is testing

Relationship Between 18FDG PET/MRI Patterns and ctDNA to Predict HCC Recurrence After Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 20
Not applicableNot Yet RecruitingNCT07833891
What this trial is testing

Senocohort: Identification of Predictive Biomarkers in Breast Cancer Treatment

Who this might be right for
Breast CancerBreast Cancer (Triple Negative Type)
Assistance Publique - Hôpitaux de Paris 500
Next Page